ABSTRACT

Volume II Drug Regulation Reform--Oversight: Orphan Drugs, Hearing Before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-Sixth Congress, Second Session, June 26, 1980   [open pdf - 42MB]

This is the June 26, 1980 hearing on "Volume II Drug Regulation Reform--Oversight: Orphan Drugs," held before the House Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce. From the Opening Statement of Henry A. Waxman: "This is the second in a series of oversight hearings on the way the Food and Drug Administration regulates research, development, and marketing of drugs. I expect that during this series of hearings the subcommittee will receive testimony on the important aspects of drug development and regulation." Statements, letters, and materials submitted for the record include those of the following: Seymour Cohen, Sharon Roubeck Dobkin, Marion Finkel, Elizabeth Holtzman, Abbey Meyers, Saul Schepartz, Adam Seligman, David Tilson, and Melvin Van Woert.

Report Number:
Serial No. 96-216
Publisher:
Date:
1980
Copyright:
Public Domain
Retrieved From:
U.S. Government Publishing Office: http://www.gpo.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations